• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氟康唑治疗实验性隐球菌性脑膜炎:剂量及联合氟胞嘧啶对真菌学和病理生理学结果的影响。

Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.

作者信息

Kartalija M, Kaye K, Tureen J H, Liu Q, Täuber M G, Elliott B R, Sande M A

机构信息

Infectious Diseases Laboratory, San Francisco General Hospital, CA 94143-0811, USA.

出版信息

J Infect Dis. 1996 May;173(5):1216-21. doi: 10.1093/infdis/173.5.1216.

DOI:10.1093/infdis/173.5.1216
PMID:8627075
Abstract

Fluconazole is effective in the therapy of cryptococcal meningitis in patients with AIDS. The optimal dosage of fluconazole and the impact of combination with flucytosine are not known. In this study, rabbits with experimental cryptococcal meningitis were given fluconazole at low, intermediate, or high dose or in combination with a low or intermediate dose of flucytosine. Serial cerebrospinal fluid (CSF) examinations showed that all three doses of fluconazole and low-dose fluconazole in combination with intermediate-dose flucytosine were effective in reducing CSF cryptococcal titer, lactate, white blood cell count, and cryptococcal antigen (CRAG) titers. The intermediate and high doses of fluconazole reduced CSF fungal (P < .05) and CRAG (P < .001) titers earlier than low-dose fluconazole alone or in combination with flucytosine. Only the highest dose of fluconazole reduced brain edema after 7 days. In this model of cryptococcal meningitis, there was evidence of a dose response with fluconazole but no in vivo synergism with flucytosine.

摘要

氟康唑对艾滋病患者的隐球菌性脑膜炎治疗有效。氟康唑的最佳剂量以及与氟胞嘧啶联合使用的效果尚不清楚。在本研究中,给患有实验性隐球菌性脑膜炎的兔子分别给予低、中、高剂量的氟康唑,或与低剂量或中剂量的氟胞嘧啶联合使用。连续的脑脊液(CSF)检查表明,所有三种剂量的氟康唑以及低剂量氟康唑与中剂量氟胞嘧啶联合使用均能有效降低脑脊液中的隐球菌滴度、乳酸水平、白细胞计数和隐球菌抗原(CRAG)滴度。氟康唑的中、高剂量比单独使用低剂量氟康唑或与氟胞嘧啶联合使用能更早地降低脑脊液真菌(P <.05)和CRAG(P <.001)滴度。仅最高剂量的氟康唑在7天后可减轻脑水肿。在这个隐球菌性脑膜炎模型中,有证据表明氟康唑存在剂量反应,但与氟胞嘧啶无体内协同作用。

相似文献

1
Treatment of experimental cryptococcal meningitis with fluconazole: impact of dose and addition of flucytosine on mycologic and pathophysiologic outcome.氟康唑治疗实验性隐球菌性脑膜炎:剂量及联合氟胞嘧啶对真菌学和病理生理学结果的影响。
J Infect Dis. 1996 May;173(5):1216-21. doi: 10.1093/infdis/173.5.1216.
2
Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial.HIV 相关隐球菌性脑膜炎的联合抗真菌治疗:一项随机试验。
Lancet. 2004 May 29;363(9423):1764-7. doi: 10.1016/S0140-6736(04)16301-0.
3
Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.氟康唑与氟胞嘧啶联合治疗隐球菌性脑膜炎小鼠模型的研究
Antimicrob Agents Chemother. 1997 May;41(5):1120-3. doi: 10.1128/AAC.41.5.1120.
4
AMBIsome Therapy Induction OptimisatioN (AMBITION): High Dose AmBisome for Cryptococcal Meningitis Induction Therapy in sub-Saharan Africa: Study Protocol for a Phase 3 Randomised Controlled Non-Inferiority Trial.两性霉素B脂质体治疗诱导优化(AMBITION):撒哈拉以南非洲地区高剂量两性霉素B脂质体用于隐球菌性脑膜炎诱导治疗:一项3期随机对照非劣效性试验的研究方案
Trials. 2018 Nov 23;19(1):649. doi: 10.1186/s13063-018-3026-4.
5
Effect of fluconazole on fungicidal activity of flucytosine in murine cryptococcal meningitis.氟康唑对氟胞嘧啶在小鼠隐球菌性脑膜炎中杀菌活性的影响。
Antimicrob Agents Chemother. 1996 Sep;40(9):2178-82. doi: 10.1128/AAC.40.9.2178.
6
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.氟胞嘧啶与高剂量氟康唑联合治疗与氟康唑单药治疗隐球菌性脑膜炎的随机试验:来自马拉维的研究。
Clin Infect Dis. 2010 Feb 1;50(3):338-44. doi: 10.1086/649861.
7
Treatment of acute cryptococcal meningitis in HIV infected adults, with an emphasis on resource-limited settings.艾滋病毒感染成人急性隐球菌性脑膜炎的治疗,重点关注资源有限的环境。
Cochrane Database Syst Rev. 2008 Oct 8(4):CD005647. doi: 10.1002/14651858.CD005647.pub2.
8
Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients.乌干达艾滋病患者中新隐球菌分离株的分子流行病学及抗真菌药敏性
Diagn Microbiol Infect Dis. 1998 Nov;32(3):191-9. doi: 10.1016/s0732-8893(98)00095-9.
9
Amphotericin B with or without flucytosine followed by fluconazole as primary therapy for cryptococcal meningitis in patients with AIDS.两性霉素B联合或不联合氟胞嘧啶,随后使用氟康唑作为艾滋病患者隐球菌性脑膜炎的初始治疗。
Southeast Asian J Trop Med Public Health. 1996 Dec;27(4):719-23.
10
Triple therapy versus amphotericin B plus flucytosine for the treatment of non-HIV- and non-transplant-associated cryptococcal meningitis: retrospective cohort study.三联疗法与两性霉素B加氟胞嘧啶治疗非HIV和非移植相关隐球菌性脑膜炎的回顾性队列研究
Neurol Res. 2018 May;40(5):398-404. doi: 10.1080/01616412.2018.1447319. Epub 2018 Mar 21.

引用本文的文献

1
New Approaches for Cryptococcosis Treatment.隐球菌病治疗的新方法。
Microorganisms. 2020 Apr 23;8(4):613. doi: 10.3390/microorganisms8040613.
2
Population Pharmacokinetics and Cerebrospinal Fluid Penetration of Fluconazole in Adults with Cryptococcal Meningitis.氟康唑在隐球菌性脑膜炎成人患者中的群体药代动力学和脑脊液穿透性。
Antimicrob Agents Chemother. 2018 Aug 27;62(9). doi: 10.1128/AAC.00885-18. Print 2018 Sep.
3
HIV-Associated Cryptococcal Disease in Resource-Limited Settings: A Case for "Prevention Is Better Than Cure"?
资源有限环境下的HIV相关隐球菌病:“预防胜于治疗”是否成立?
J Fungi (Basel). 2017 Dec 2;3(4):67. doi: 10.3390/jof3040067.
4
Flucytosine and cryptococcosis: time to urgently address the worldwide accessibility of a 50-year-old antifungal.氟胞嘧啶与隐球菌病:是时候紧急解决全球范围内使用一种有 50 年历史的抗真菌药物的可及性问题了。
J Antimicrob Chemother. 2013 Nov;68(11):2435-44. doi: 10.1093/jac/dkt221. Epub 2013 Jun 20.
5
Pharmacokinetics and pharmacodynamics of fluconazole for cryptococcal meningoencephalitis: implications for antifungal therapy and in vitro susceptibility breakpoints.氟康唑治疗隐球菌性脑膜脑炎的药代动力学和药效学:对抗真菌治疗和体外药敏折点的影响。
Antimicrob Agents Chemother. 2013 Jun;57(6):2793-800. doi: 10.1128/AAC.00216-13. Epub 2013 Apr 9.
6
Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america.《隐球菌病治疗指南:美国传染病学会 2010 年更新版》
Clin Infect Dis. 2010 Feb 1;50(3):291-322. doi: 10.1086/649858.
7
Combination flucytosine and high-dose fluconazole compared with fluconazole monotherapy for the treatment of cryptococcal meningitis: a randomized trial in Malawi.氟胞嘧啶与高剂量氟康唑联合治疗与氟康唑单药治疗隐球菌性脑膜炎的随机试验:来自马拉维的研究。
Clin Infect Dis. 2010 Feb 1;50(3):338-44. doi: 10.1086/649861.
8
Antifungal combination therapy: clinical potential.抗真菌联合治疗:临床潜力。
Drugs. 2005;65(11):1461-80. doi: 10.2165/00003495-200565110-00002.
9
In vitro interaction of flucytosine with conventional and new antifungals against Cryptococcus neoformans clinical isolates.氟胞嘧啶与传统及新型抗真菌药物对新型隐球菌临床分离株的体外相互作用。
Antimicrob Agents Chemother. 2003 Oct;47(10):3361-4. doi: 10.1128/AAC.47.10.3361-3364.2003.
10
Combination therapy with fluconazole and flucytosine in the murine model of cryptococcal meningitis.氟康唑与氟胞嘧啶联合治疗隐球菌性脑膜炎小鼠模型的研究
Antimicrob Agents Chemother. 1997 May;41(5):1120-3. doi: 10.1128/AAC.41.5.1120.